Skip to main content

Chemometec

ChemoMetec A/S is a Danish medical technology company specializing in the development, manufacturing, and global commercialization of automated cell counting and cell analysis equipment. The company designs specialized analytical instruments, including its signature NucleoCounter product line, alongside proprietary disposable sampling cassettes, reagents, and image analysis software. Its automated systems are extensively utilized in cell-based immunotherapy research, biopharmaceutical manufacturing quality control, veterinary science, and academic life science research facilities. Principal revenue is derived from the direct commercial sale of analytical instruments, recurring high-margin sales of single-use sampling cassettes, software subscription licenses, and comprehensive equipment maintenance service agreements. ChemoMetec maintains a dominant market position in automated cell counting technology utilized within advanced cell and gene therapy manufacturing workflows globally. Headquartered in Allerød, Denmark, the company operates international sales subsidiaries across North America and Europe, with its common shares publicly listed and traded on Nasdaq Copenhagen under the ticker CHEMM.

20 of the funds FundTelligence covers report a position in Chemometec.

Legal name
Chemometec AS
Sector
Health Care
Country
Denmark
Funds holding it
20

Funds holding Chemometec

Showing the 8 largest of 20 funds holding it.

Loading...